# Intellia Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/intellia-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-05T15:31:29.535299+00:00 | | Last reviewed | 2026-10-05T15:31:29.535299+00:00 | ## Identity - Legal name: Intellia Therapeutics, Inc. - Display name: Intellia Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-06T03:36:32.77979+00:00 | | Completeness | 0.364 | | Record Quality | 0.827 | | Directors | 12 | | Committees | 0 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian Goff: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:6 - By Mail: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:7 - Frank Verwiel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:8 - Jesse Goodman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:11 - Muna Bhanji: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:14 - William Chase: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:16 - Frank Verwiel, M.D.: Chairperson of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:5 - Fred Cohen, M.D., D.Phil.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:9 - Georgia Keresty, Ph.D., M.P.H.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:10 - Jesse Goodman, M.D., M.P.H.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:12 - John M. Leonard, M.D.: President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:13 - Muna Bhanji, R.Ph.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:15 ## Executive leadership - Bradley T. Sheares, Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:18 - Birgit Schultes, Ph.D.: Executive Vice President, Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:17 - David Lebwohl, M.D.: Executive Vice President, Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:19 - Edward J. Dulac III: Executive Vice President, Chief Financial Officer and Treasurer [CFO]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:20 - James Basta, J.D.: Executive Vice President, General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:21 - John M. Leonard, M.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:22 ## Governance events - DIRECTOR_APPOINTED: Brian Goff seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:7lnbgg - DIRECTOR_APPOINTED: By Mail seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1nfu16z - DIRECTOR_APPOINTED: Frank Verwiel seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1f0nveu - EXECUTIVE_APPOINTED: Bradley T. Sheares, Ph.D. executive of Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:executive_appointed:aw2oue - DIRECTOR_APPOINTED: William Chase seat on Intellia Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1qqptoe - DIRECTOR_APPOINTED: Muna Bhanji seat on Intellia Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1887745 - DIRECTOR_APPOINTED: Jesse Goodman seat on Intellia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:ef2ubd ## Scoped resources - `alpha://company/intellia-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record - `alpha://company/intellia-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=identity - `alpha://company/intellia-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/intellia-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=board - `alpha://company/intellia-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=committees - `alpha://company/intellia-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=leadership - `alpha://company/intellia-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ownership - `alpha://company/intellia-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=financials - `alpha://company/intellia-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/intellia-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=compensation - `alpha://company/intellia-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=governance - `alpha://company/intellia-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/intellia-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=audit - `alpha://company/intellia-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=legal - `alpha://company/intellia-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=risk - `alpha://company/intellia-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=cyber - `alpha://company/intellia-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/intellia-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=agents - `alpha://company/intellia-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/intellia-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=events - `alpha://company/intellia-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=relationships - `alpha://company/intellia-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=assessments - `alpha://company/intellia-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Frank Verwiel, M.D.: Chairperson of the Board. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Brian Goff: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:6. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - By Mail: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:7. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - Frank Verwiel: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:8. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - Fred Cohen, M.D., D.Phil.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Georgia Keresty, Ph.D., M.P.H.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Jesse Goodman: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - Jesse Goodman, M.D., M.P.H.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - John M. Leonard, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Muna Bhanji: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:14. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - Muna Bhanji, R.Ph.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - William Chase: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:16. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f. - Birgit Schultes, Ph.D.: Executive Vice President, Chief Scientific Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Bradley T. Sheares, Ph.D.: Named Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d803c5efef632f1e8319f272449efc903a6351aa4d50b90487317a005dddc5f5. - David Lebwohl, M.D.: Executive Vice President, Chief Medical Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - Edward J. Dulac III: Executive Vice President, Chief Financial Officer and Treasurer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - James Basta, J.D.: Executive Vice President, General Counsel and Corporate Secretary. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. - John M. Leonard, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Intellia Therapeutics, Inc.. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b. ## Entity Status - Public listing published. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b. ## Published Fact - US. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b. ## Security Listing - NTLA (NASDAQ). Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/intellia-therapeutics-inc). - alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9: [SEC DEF 14A 0001193125-26-197283](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm). - alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f: [DEF 14A ntla-20260430.htm](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm). - alpha:projection-evidence:document:d803c5efef632f1e8319f272449efc903a6351aa4d50b90487317a005dddc5f5: [NTLA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/intellia-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/intellia-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/intellia-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-06T03:36:32.779659+00:00; recorded 2026-10-06T03:36:32.779659+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.